We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Global ELISA Kits Market to Surpass USD 418.5 Billion by 2025

By LabMedica International staff writers
Posted on 09 Mar 2020
The global ELISA (Enzyme-Linked Immunosorbent Assay) Kits market is projected to grow at a CAGR of 3.8% to surpass USD 418.5 billion by the year 2025, driving a CAGR of 4% in the worldwide Research ELISA market which is expected to reach USD 143.7 billion.

These are the latest findings of Global Industry Analysts, Inc. More...
(San Jose, CA, USA), a publisher of off-the-shelf market research.

Within the developed world, the ELISA Kits market in the US is projected to maintain a growth of 3.1%. Within Europe, which remains an important element in the world economy, Germany will add over USD 5.2 billion to the region's ELISA Kits market over the next five to six years. Over USD 4.2 billion worth of projected demand for ELISA kits in the region is expected to come from the Rest of Europe markets.

The Japanese ELISA Kits market is expected to reach a size of USD 24.4 billion by 2025. As the world's second-largest economy and the new game changer in the global markets, China’s ELISA Kits market is projected to grow at 6.2% over the next couple of years and add approximately USD 40.1 billion in terms of addressable opportunity. Several macroeconomic factors and internal market forces will shape the growth and development of demand patterns of the ELISA Kits market in the emerging countries in Asia-Pacific, Latin America and the Middle East.

Related Links:
Global Industry Analysts, Inc.


New
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
New
Gold Member
Neonatal Heel Incision Device
Tenderfoot
New
Repetitive Pipette
VWR® Stepper Pro
New
Automated Clinical Chemistry Analyzer
Envoy 500+
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image

Urine-Based Multi-Cancer Screening Test Receives FDA Breakthrough Device Designation

Early detection across multiple cancers remains a major unmet need in population screening. Non-invasive approaches that can be delivered at scale may broaden access and shift diagnoses to earlier stages.... Read more

Molecular Diagnostics

view channel
Image: The new approach focuses on CpG DNA methylation, a chemical modification of cytosine and guanine bases, using tumor samples to develop a computational model that distinguishes among 21 cancer types (photo credet: 123RF)

Machine Learning Model Uses DNA Methylation to Predict Tumor Origin in Cancers of Unknown Primary

Cancers of unknown primary (CUP) are metastatic malignancies in which the primary site cannot be identified, complicating treatment selection. Many patients consequently receive broad, nonspecific chemotherapy... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.